Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor.
Year: 1992
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Authors: H M Kantarjian, M Talpaz, D Kontoyiannis, J Gutterman, M J Keating, E H Estey, S O'Brien, M B Rios, M Beran, A Deisseroth
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Awards: The Therapy of CML, G996741727
OpenAlex ID: W1830468795